Clinician and Institution Profile
Academic Institution (Hub-and-Spoke Model)
The Cleveland Clinic Main Campus
Cleveland, OH
Type of Facility: Academic
Type of Control: Voluntary non-profit
Total Staffed Beds: 1,326
Total Patient Revenue: $20,807,393,423
Total Discharges: 50,013
Total Patient Days: 367,453
LungVisionTM Acquisition: 2021
Fairview Hospital
Cleveland, OH
Type of Facility: Academic (Satellite Hospital)
Type of Control: Voluntary non-profit
Total Staffed Beds: 466
Total Patient Revenue: $1,968,777,773
Total Discharges: 24,027
Total Patient Days: 115,711
LungVisionTM Acquisition: 2022
Joseph Cicenia, MD
Interventional Pulmonologist,
The Cleveland Clinic
Cleveland, OH
LungVisionTM Trained: 2019
Sonali Sethi, MD
Interventional Pulmonologist,
The Cleveland Clinic
Cleveland, OH
LungVisionTM Trained: 2019
Michael Machuzak, MD
Interventional Pulmonologist,
The Cleveland Clinic
Cleveland, OH
LungVisionTM Trained: 2019
Background
- LungVision™ prototype placed at The Cleveland Clinic Main Campus in 2019 for registry trial and product development
- Initially used standalone for advanced navigation and real-time, intraoperative imaging.
- Acquired Ethicon Monarch (2021) and Ion by Intuitive (2022) robotic bronchoscopy platforms, but IP team continues to use LungVision™ as standalone system for some cases and as real-time, intraoperative imaging adjunct to robotic platforms.
- LungVision™ system at The Cleveland Clinic Main Campus upgraded to full commercial system in 2021 upon purchase.
- Second LungVision™ system acquired for Fairview Hospital (satellite hospital) in 2022 justified due to cost savings over alternative advanced navigation platforms such as electromagnetic navigation and robotics.
Clinical and Financial Impact
Based on data presented by Joseph Cicenia, MD.1
Takeaway
The Cleveland Clinic’s acquisition of LungVision™ AI-driven image guidance for both Main Campus and Fairfield Hospital enabled them to:
- Improve their diagnostic yield by 14.5% (from 74% to 88%) over superD and/or a pre-production version of LungVision™, which translates to an estimated 202 additional diagnosed individuals and $4.4M in incremental downstream revenue
- Save an estimated $2,700 per case when using LungVision™ standalone for navigation and real-time imaging compared with using a robotic bronchoscopy platform
Sources
¹Cicenia, J. (2023, August 24). The Cleveland Clinic Experience: Integrating Real-Time Image Guidance in a Hub-and-Spoke Model. American Association for Bronchology and Interventional Pulmonology 6th Annual Conference. Chicago, Illinois, USA. (bodyvisionmedical.com/videos/aabip-2023-lunchsymposium). ²Incremental downstream revenue based on number of additional diagnosed patients from increase in 14.5% diagnostic yield, assumptions that 50% of additional diagnosed patients diagnosed with cancer, 28% private payor / 72% Medicare-Medicaid payor mix, with 35% undergoing radiation therapy, 15% undergoing lung resection, 50% undergoing chemotherapy, 80% undergoing PET scans, 100% undergoing additional CT scans, and 100% undergoing pulmonary function test reimbursed at the national average for the appropriate CPT code. ³Based on estimated $2,000 increase in robotic per-case costs.